Bio-Gene Technology Company Description

Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally.

Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone.

The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activity of its molecules against a range of insect species; Advanced Molecular Technologies; CSIRO for a chemistry development process; the Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University for chemical analysis of natural products; University of Florida; and University of Technology.

It serves animal health, crop protection, grain storage, public health, and consumer applications, as well as insect management in crop protection.

The company was incorporated in 1995 and is based in Melbourne, Australia.

Bio-Gene Technology Limited

Country	Australia
Founded	1995
Industry	Biotechnology
Sector	Healthcare
CEO	Timothy Grogan

Contact Details

Address: 400 Collins Street Melbourne, VIC 3000 Australia
Phone	61 3 9068 1062
Website	bio-gene.com.au

Stock Details

Ticker Symbol	BGT
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000BGT8
SIC Code	2870

Key Executives

Name	Position
Timothy Owen Grogan B.Sc., LLB	MD, Chief Executive Officer and Director
Edmond Tern B.A., CPA	Chief Financial Officer and Company Secretary
Peter Donald May AFA1M, AFAIM, GAICD, M.B.A.	Executive Director of Research and Development and Executive Director